IRINOTECAN ZENITH

IRINOTECAN TRHYDRATE CHLORHYDRATE

Public price

499,00 MAD

Active substance

IRINOTECAN TRHYDRATE CHLORHYDRATE

Laboratory

ZENITH PHARMA

What is this medicine?

IRINOTECAN ZENITH: This substance is an antineoplastic treatment used in oncology. It is reserved for specialist supervised protocols.

Verified summary

IRINOTECAN TRHYDRATE CHLORHYDRATE, SOLUTION A DILUER POUR PERFUSION, 40 MG / 2 ML, BOITE DE 1 FLACON DE 5 ML

Common uses

Common uses: solid or haematological cancers depending on the molecule, stage, protocol, and oncology-team decision. General use context: injectable or infusion form, usually used under healthcare-professional supervision.

Class

Oncology - antineoplastic

Laboratory

ZENITH PHARMA

Hospital price

331,00 MAD

Strength

40 MG / 2 ML

Form

SOLUTION A DILUER POUR PERFUSION

Presentation

BOITE DE 1 FLACON DE 5 ML

Commercial status

Commercialisé

This information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.

Price history

Reference price recorded since 2026-06-01: 499,00 MAD

Available presentations and strengths